Evidence map›Paper›PMID 39613864›Full record

ArticleScientific reports2024

Reversible stochastic epigenetic like silencing of the production of pulcherriminic acid in the antimicrobial antagonist Metschnikowia Pulcherrima.

Matthias Sipiczki, Kinga Czentye

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Pulcherrimin and Beyond: The Multifaceted Role ofJournal of fungi (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Potential ofFrontiers in microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthias SipiczkiDepartment of Genetics and Applied Microbiology, University of Debrecen, Debrecen, Hungary. gecela@post.sk.
Kinga CzentyeDepartment of Genetics and Applied Microbiology, University of Debrecen, Debrecen, Hungary.

Funding

National Research, Development and Innovation Fund Office, Hungary 2020-1.1.2-PIACI-KFI-2020-00130
6 · The paper itself

Abstract

The ability to produce pulcherriminic acid is a characteristic feature of yeast species of the pulcherrima clade recently merged under the taxonomic name Metschnikowia pulcherrima. This iron chelator cyclodipeptide forms pulcherrimin, a maroon-red pigment with ferric ions. Its synthesis and secretion into the environment is under the control of closely linked genes referred to as the PUL cluster. The examination of 18 generations of single-cell clones generated from a stock culture of the collection strain 11-1090 (CBS 10359) in this study revealed that the biosynthesis of pulcherriminic acid is reversibly switched on and off during the propagation of cells in a way similar to the epigenetic silencing and activation of gene expression (bimodal active/silent state) in near-heterochromatic regions of other yeast species. As the strain is heterozygous for PUL2 alleles encoding slightly different amino acid sequences and has a plastic genome structure, the efficiency of pulcherriminic acid synthesis in the switched-on state is presumed to depend on which PUL2 allele is active and on structural changes in the genome. The transitions between the active and silent states of pulcherriminic acid synthesis are associated with transitions between the active and silent states of antimicrobial antagonism. This association confirms the primary role of pulcherriminic acid in the antimicrobial antagonism of M. pulcherrima.

Indexed as

Epigenesis, GeneticMetschnikowiaGene Expression Regulation, FungalGene SilencingIndenesPyrazinesIndenespulcherriminic acidPyrazinesAntagonistic yeastPulcherriminPUL clusterSegregationVariegation

Identifiers

PMID39613864
PMCPMC11607323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.